Weisman Harlan F 4
4 · TFF Pharmaceuticals, Inc. · Filed Dec 3, 2019
Insider Transaction Report
Form 4
Weisman Harlan F
DirectorPresident and CEO
Transactions
- Award
Stock Options (Right to Buy)
[F1]2019-11-29+3,623→ 139,429 totalExercise: $5.00Exp: 2029-10-29→ Common Stock (3,623 underlying)
Footnotes (1)
- [F1]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
Signature
/s/ Harlan F. Weisman, M.D., by Kirk Allen Coleman, as Attorney-in-Fact|2019-12-03